Strategies for decision-making on vaccine use: the French experience

@article{Loulergue2015StrategiesFD,
  title={Strategies for decision-making on vaccine use: the French experience},
  author={Pierre Loulergue and Daniel Floret and Odile Launay},
  journal={Expert Review of Vaccines},
  year={2015},
  volume={14},
  pages={917 - 922}
}
France enjoys benefits of a good organization of its healthcare system. National Health Insurance is reimbursing vaccines if they are used according to the national recommendation guidelines. Vaccination is the responsibility of the government, advised by its National Immunization Technical Advisory Group (Comité Technique des vaccinations). But France, like many other countries, faces insufficient involvement from the public in immunization programs and, consequently, numerous outbreaks of… 
View on Taylor & Francis
ncbi.nlm.nih.gov
5 Citations
Background Citations
1

5 Citations

Strategies implemented to address vaccine hesitancy in France: A review article
  • C. Fokoun
  • Medicine, Political Science
    Human vaccines & immunotherapeutics
  • 2018
TLDR
The results indicate that different strategies have been proposed to reach this goal, mainly by vaccination campaigns, and further studies are required to identify the most effective strategies to address vaccine hesitancy.
Vaccine market access pathways in the EU27 and the United Kingdom - analysis and recommendations for improvements.
Contemporary vaccination policy in the European Union: tensions and dilemmas
TLDR
By systematically acknowledging the nuances of political and institutional varieties, the case for reframing the terms of the debate in the EU and beyond is built.
Élaboration de la politique vaccinale
  • D. Floret
  • Political Science
    Revue des Maladies Respiratoires
  • 2019
Vaccination
  • D. Floret
  • Journal de Pédiatrie et de Puériculture
  • 2021

References

SHOWING 1-10 OF 30 REFERENCES
The French Technical Vaccination Committee (CTV).
HPV vaccination in France: uptake, costs and issues for the National Health Insurance.
Vaccine-preventable diseases in Europe: where do we stand?
TLDR
More flexible vaccine delivery platforms are needed targeting the less-privileged people, especially in the context of the current economic crisis, and healthcare personnel and healthcare systems should be prepared to address these challenges in the following years.
Influenza vaccination acceptance among health-care workers: a nationwide survey.
Civil society: a critical new advocate for vaccination in Europe.
Evolution of hepatitis B vaccine coverage rates in France between 2008 and 2011.
Healthcare worker compliance with seasonal and pandemic influenza vaccination
TLDR
A review of the literature on demographic factors, fears and concerns over vaccine safety and efficacy, perceptions of risk and personal vulnerability, past vaccination behaviours and experience with influenza illness, as well as certain situational and organisational constructs are reported.
Vaccinations among medical and nursing students: coverage and opportunities.
Vaccine coverage of healthcare students in hospitals of the Paris region in 2009: the Studyvax survey.
Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States.
TLDR
The number of cases of most vaccine-preventable diseases is at an all-time low; hospitalizations and deaths have also shown striking decreases.
...
...